Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Creo Medical Group PLC

Creo Medical Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)26.68
  • Today's Change-0.075 / -0.28%
  • Shares traded2.99k
  • 1 Year change-15.32%
  • Beta1.2005
Data delayed at least 15 minutes, as of Sep 30 2024 08:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade Creo Medical Group PLC (CREO:LSE) traded at 26.68, 4.61% above its 52-week low of 25.50, set on Sep 23, 2024.
52-week range
Today
25.50Sep 23 202450.00Jan 02 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open26.75
High26.68
Low26.00
Bid26.50
Offer27.00
Previous close26.75
Average volume1.25m
Shares outstanding361.78m
Free float280.93m
P/E (TTM)--
Market cap102.98m GBP
EPS (TTM)-0.0709
GBP
Data delayed at least 15 minutes, as of Sep 30 2024 08:08 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.